We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Weight Loss Surgery Might Protect Against Cardiovascular Events

By HospiMedica International staff writers
Posted on 18 Jan 2012
Bariatric surgery in obese individuals was associated with a reduced long-term incidence of cardiovascular (CV) events and death, according to a new study.

Researchers at the University of Gothenburg (Sweden) conducted a nonrandomized, prospective, controlled study of 2,010 obese participants who underwent bariatric surgery and 2,037 contemporaneously matched obese controls to evaluate the association between bariatric surgery, weight loss, and CV events during a median follow-up of 14.7 years. More...
Inclusion criteria were age 37 to 60 years and a body mass index (BMI) of at least 34 in men, and at least 38 in women. The surgery patients underwent gastric bypass (13.2%), banding (18.7%), or vertical banded gastroplasty (68.1%), while the controls received usual care in the Swedish primary health care system. The main outcome measure was total mortality. Myocardial infarction (MI) and stroke were predefined secondary end points, considered separately, and combined.

The results showed that bariatric surgery was associated with a reduced number of CV deaths (28 events in the surgery group compared to 49 events in the control group). The number of total first time (fatal or nonfatal) CV events (MI or stroke, whichever came first) was also lower in the surgery group (199 events among 2,010 patients) than in the control group (234 events among 2,037 patients). On the other hand, the researchers found no significant relationship between weight change and cardiovascular events in the surgery or control group. The study was published in the January 4, 2012, issue of the Journal of the American Medical Association (JAMA).

“These results together with our previously reported associations between bariatric surgery and favorable outcomes regarding long-term changes of body weight, cardiovascular risk factors, quality of life, diabetes, cancer, and mortality demonstrate that there are many benefits to bariatric surgery and that some of these benefits are independent of the degree of the surgically induced weight loss,” concluded lead author Lars Sjostrom, MD, PhD, and colleagues of the institute of medicine.

Related Links:
University of Gothenburg



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.